BALAXI PHARMACEUTICALS
Back to Income Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹336 Cr | ₹279 Cr | ₹231 Cr | ₹46 Cr | ₹1,360 Cr |
What is the latest Revenue of BALAXI PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹336 Cr |
Mar2023 | ₹279 Cr |
Mar2022 | ₹231 Cr |
Mar2021 | ₹46 Cr |
Mar2020 | ₹1,360 Cr |
How is Revenue of BALAXI PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹336 Cr | 20.42 | |
Mar2023 | ₹279 Cr | 20.77 | |
Mar2022 | ₹231 Cr | 406.94 | |
Mar2021 | ₹46 Cr | -96.64 | |
Mar2020 | ₹1,360 Cr | - |
Compare Revenue of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹270.4 Cr | 0% | -7.4% | -56.4% | Stock Analytics | |
ADANI ENTERPRISES | ₹295,742.0 Cr | -0.4% | 0.8% | -17% | Stock Analytics | |
REDINGTON | ₹23,433.7 Cr | -3.3% | 0.1% | 43.3% | Stock Analytics | |
LLOYDS ENTERPRISES | ₹11,531.8 Cr | 1.1% | 24.6% | 141.3% | Stock Analytics | |
MMTC | ₹10,198.5 Cr | -2.4% | -4.7% | -18.5% | Stock Analytics | |
HONASA CONSUMER | ₹9,573.4 Cr | -0.7% | -5.6% | -33.7% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | 0% |
-7.4% |
-56.4% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses